Mishra Ribhav, Joshi Vibhuti, Upadhyay Arun, Amanullah Ayeman, Dubey Ankur Rakesh, Singh Sarika, Dubey Vikash Kumar, Poluri Krishna Mohan, Jana Nihar Ranjan, Mishra Amit
Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan 342037, India.
Department of Neuroscience and Ageing Biology and Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow 226031, UP, India.
Cell Signal. 2021 Jan;77:109836. doi: 10.1016/j.cellsig.2020.109836. Epub 2020 Nov 15.
Numerous proteins participate and actively contribute to the various cellular mechanisms, where several of them are crucial for regular metabolism, including survival. Thus, to maintain optimal cellular physiology, cells govern protein quality control functions with the assistance of comprehensive actions of molecular chaperones, the ubiquitin-proteasome system, and autophagy. In the ubiquitin-proteasome pathway, few quality control E3 ubiquitin ligases actively participate against misfolded protein aggregation generated via stress conditions. But how these quality control E3s active expression levels returned to basal levels when cells achieved re-establishment of proteostasis is still poorly understood. Our current study demonstrated that LRSAM1 E3 ubiquitin ligase promotes the proteasomal degradation of quality control E3 ubiquitin ligase E6-AP. We have observed the co-localization and recruitment of LRSAM1 with E6-AP protein and noticed that LRSAM1 induces the endogenous turnover of E6-AP. Partial depletion of LRSAM1 elevates the levels of E6-AP and affects overall cell cycle regulatory proteins (p53 and p27) expression, including the rate of cellular proliferation. The current finding also provides an excellent opportunity to better understand the basis of the E6-AP associated pathomechanism of Angelman Syndrome disorder. Additionally, this study touches upon the novel potential molecular strategy to regulate the levels of one quality control E3 ubiquitin ligase with another E3 ubiquitin ligase and restore proteostasis and provide a possible therapeutic approach against abnormal protein aggregation diseases.
众多蛋白质参与并积极促成各种细胞机制,其中一些对包括细胞存活在内的正常新陈代谢至关重要。因此,为维持最佳细胞生理状态,细胞在分子伴侣、泛素 - 蛋白酶体系统和自噬的综合作用协助下进行蛋白质质量控制功能。在泛素 - 蛋白酶体途径中,少数质量控制E3泛素连接酶积极参与应对应激条件下产生的错误折叠蛋白聚集。但当细胞实现蛋白质稳态重建时,这些质量控制E3的活性表达水平如何恢复到基础水平仍知之甚少。我们目前的研究表明,LRSAM1 E3泛素连接酶促进质量控制E3泛素连接酶E6 - AP的蛋白酶体降解。我们观察到LRSAM1与E6 - AP蛋白的共定位和募集,并注意到LRSAM1诱导E6 - AP的内源性周转。LRSAM1的部分缺失会提高E6 - AP的水平,并影响包括细胞增殖速率在内的整体细胞周期调节蛋白(p53和p27)的表达。目前的发现也为更好地理解天使综合征E6 - AP相关发病机制的基础提供了绝佳机会。此外,本研究涉及一种新的潜在分子策略,即通过另一种E3泛素连接酶调节一种质量控制E3泛素连接酶的水平,恢复蛋白质稳态,并为对抗异常蛋白聚集疾病提供一种可能的治疗方法。